Pharma Journalist -

Merck, known as MSD outside the United States and Canada, announced it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of…
Read More...

Oscotec Inc. the Korean drug development company, and Beactica Therapeutics AB, the Swedish drug discovery company, announced a new research development and licensing agreement. Oscotec…
Read More...

Iktos announced the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few years,…
Read More...

SMi reports: Exclusive Co-Chair letter invitation released for the upcoming Pre-Filled Syringes West Coast 2021 SMi are delighted to have Tina Rees, Associate Director, Regeneron…
Read More...

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic…
Read More...

HitGen announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc. to identify small molecule Hits against previous known-to-be undruggable targets and…
Read More...

Boehringer Ingelheim and Gubra announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the…
Read More...

Partner Therapeutics, Inc. (PTx) announced top-line results of the investigator-led SARPAC (Sargramostim in Patients with Acute Hypoxic Respiratory Failure and Acute COVID-19) study of…
Read More...

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany, a leading…
Read More...

SMi Reports: Exploring the challenges, practices and drivers in the aftermath of the transition for Parallel Trade Join us at SMi’s 15th annual Parallel Trade Conference bringing…
Read More...